rs6505592

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378183.1(PIEZO2):​c.2305C>T​(p.Leu769Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.863 in 1,529,326 control chromosomes in the GnomAD database, including 570,175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.85 ( 54824 hom., cov: 31)
Exomes 𝑓: 0.86 ( 515351 hom. )

Consequence

PIEZO2
NM_001378183.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.59

Publications

16 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 18-10787049-G-A is Benign according to our data. Variant chr18-10787049-G-A is described in ClinVar as Benign. ClinVar VariationId is 261503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.911 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.2305C>T p.Leu769Leu synonymous_variant Exon 16 of 56 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.2305C>T p.Leu769Leu synonymous_variant Exon 16 of 56 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.848
AC:
128972
AN:
152014
Hom.:
54779
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.804
Gnomad AMI
AF:
0.832
Gnomad AMR
AF:
0.874
Gnomad ASJ
AF:
0.842
Gnomad EAS
AF:
0.933
Gnomad SAS
AF:
0.856
Gnomad FIN
AF:
0.851
Gnomad MID
AF:
0.851
Gnomad NFE
AF:
0.863
Gnomad OTH
AF:
0.844
GnomAD2 exomes
AF:
0.860
AC:
121355
AN:
141046
AF XY:
0.861
show subpopulations
Gnomad AFR exome
AF:
0.792
Gnomad AMR exome
AF:
0.859
Gnomad ASJ exome
AF:
0.831
Gnomad EAS exome
AF:
0.932
Gnomad FIN exome
AF:
0.856
Gnomad NFE exome
AF:
0.865
Gnomad OTH exome
AF:
0.860
GnomAD4 exome
AF:
0.865
AC:
1190866
AN:
1377194
Hom.:
515351
Cov.:
41
AF XY:
0.864
AC XY:
587476
AN XY:
679578
show subpopulations
African (AFR)
AF:
0.801
AC:
24969
AN:
31172
American (AMR)
AF:
0.863
AC:
29533
AN:
34204
Ashkenazi Jewish (ASJ)
AF:
0.832
AC:
20816
AN:
25034
East Asian (EAS)
AF:
0.933
AC:
33272
AN:
35646
South Asian (SAS)
AF:
0.856
AC:
66597
AN:
77832
European-Finnish (FIN)
AF:
0.855
AC:
30006
AN:
35086
Middle Eastern (MID)
AF:
0.844
AC:
4749
AN:
5624
European-Non Finnish (NFE)
AF:
0.866
AC:
931331
AN:
1074890
Other (OTH)
AF:
0.859
AC:
49593
AN:
57706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
8095
16189
24284
32378
40473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20822
41644
62466
83288
104110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.848
AC:
129075
AN:
152132
Hom.:
54824
Cov.:
31
AF XY:
0.850
AC XY:
63241
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.805
AC:
33364
AN:
41468
American (AMR)
AF:
0.874
AC:
13358
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.842
AC:
2925
AN:
3472
East Asian (EAS)
AF:
0.933
AC:
4823
AN:
5170
South Asian (SAS)
AF:
0.857
AC:
4132
AN:
4824
European-Finnish (FIN)
AF:
0.851
AC:
9012
AN:
10588
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.863
AC:
58667
AN:
68008
Other (OTH)
AF:
0.845
AC:
1787
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1007
2014
3020
4027
5034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.846
Hom.:
17529
Bravo
AF:
0.847
Asia WGS
AF:
0.896
AC:
3109
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gordon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Marden-Walker syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, with impaired proprioception and touch Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.29
DANN
Benign
0.43
PhyloP100
-1.6
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6505592; hg19: chr18-10787047; COSMIC: COSV108125173; API